US2022062502A1PendingUtilityA1

Devices including muscle matrix and methods of production and use

Assignee: LIFECELL CORPPriority: Jan 30, 2017Filed: Sep 6, 2021Published: Mar 3, 2022
Est. expiryJan 30, 2037(~10.5 yrs left)· nominal 20-yr term from priority
A61L 27/367A61L 27/3687A61L 27/3691A61L 2430/30A61F 2002/0894A61L 27/04A61L 27/3873A61F 2/0063A61L 27/3683A61L 27/3645A61F 2002/0081A61F 2/08A61L 27/56A61L 27/58A61L 27/50A61L 27/18A61L 27/16A61L 27/3604
71
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Tissue compositions and methods of preparation thereof are provided. The tissue compositions can be used to treat or regenerate muscle tissue. The compositions can be configured to provide increased strength compared to other muscle matrices.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A tissue composition comprising:
 multiple layers of decellularized muscle matrix that contain at least some of the myofibers normally found in an unprocessed muscle sample, and one or more binding layers comprising particulate acellular tissue matrix (ATM) to attach the multiple layers of decellularized muscle matrix to one another.   
     
     
         2 . The tissue composition of  claim 1 , wherein the particulate ATM has been treated with a transglutaminase. 
     
     
         3 . The tissue composition of  claim 1 , wherein a direction in which the first decellularized muscle matrix layer was cut from a muscle is aligned with a direction in which the second decellularized muscle matrix layer was cut from a muscle. 
     
     
         4 . The tissue composition of  claim 1 , wherein a direction in which the first decellularized muscle matrix layer was cut from a muscle is offset from a direction in which the second decellularized muscle matrix layer was cut from a muscle. 
     
     
         5 . The tissue composition of  claim 1 , wherein the particulate ATM comprises dermal or muscle tissue matrix. 
     
     
         6 . The tissue composition of  claim 1 , wherein the particulate ATM comprises rehydrated particles. 
     
     
         7 . The tissue composition of  claim 1 , wherein the particulate ATM comprises a porous structure. 
     
     
         8 . The tissue composition of  claim 1 , wherein the particulate ATM in the binding layer is cross-linked. 
     
     
         9 . The tissue composition of  claim 1 , wherein the particulate ATM comprises muscular tissue matrix. 
     
     
         10 . The tissue composition of  claim 1 , wherein the layers of decellularized muscle matrix are further joined by interlocking pieces of the layers of decellularized muscle matrix. 
     
     
         11 . The tissue composition of  claim 1 , wherein the layers of decellularized muscle matrix comprise porcine muscle tissue. 
     
     
         12 . A tissue composition, comprising:
 a muscle matrix layer; and   a binding layer comprising particulate acellular tissue matrix (ATM) applied to the muscle matrix layer,   wherein the muscle matrix layer has been rolled such that at least a portion of a first surface of the muscle matrix layer attaches to a portion of a second surface of the muscle matrix layer.   
     
     
         13 . The tissue composition of  claim 12  further comprising a supporting layer in contact with the first surface of the muscle matrix layer. 
     
     
         14 . The tissue composition of  claim 13 , wherein at least the portion of the first surface attaches to the portion of the second surface through one or more pores in the supporting layer. 
     
     
         15 . The tissue composition of  claim 13 , wherein the supporting layer comprises a synthetic substrate. 
     
     
         16 . The tissue composition of  claim 13 , wherein the supporting layer comprises a polypropylene or metal mesh. 
     
     
         17 . The tissue composition of  claim 12 , wherein the particulate ATM has been treated with a transglutaminase. 
     
     
         18 . The tissue composition of  claim 12 , wherein the particulate ATM comprises dermal or muscle tissue matrix. 
     
     
         19 . The tissue composition of  claim 12 , wherein the particulate ATM comprises rehydrated particles. 
     
     
         20 . The tissue composition of  claim 12 , wherein the particulate ATM comprises a porous structure. 
     
     
         21 . The tissue composition of  claim 12 , wherein the particulate ATM in the binding layer is cross-linked.

Join the waitlist — get patent alerts

Track US2022062502A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.